Australia markets open in 5 hours 52 minutes

BELLUS Health Inc. (BLU)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.8600+0.1300 (+4.76%)
As of 2:05PM EDT. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 5226.88M
Enterprise value 3132.41M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)15,125.28
Price/book (mrq)1.68
Enterprise value/revenue 38,827.47
Enterprise value/EBITDA 7N/A

Trading information

Stock price history

Beta (5Y monthly) -0.68
52-week change 310.08%
S&P500 52-week change 335.56%
52-week high 34.9600
52-week low 32.0100
50-day moving average 33.0920
200-day moving average 33.7038

Share statistics

Avg vol (3-month) 3421.6k
Avg vol (10-day) 3254.12k
Shares outstanding 578.34M
Implied shares outstanding 6N/A
Float 44.66M
% held by insiders 19.41%
% held by institutions 168.71%
Shares short (14 July 2021) 41.17M
Short ratio (14 July 2021) 42.52
Short % of float (14 July 2021) 4N/A
Short % of shares outstanding (14 July 2021) 41.50%
Shares short (prior month 14 June 2021) 41.52M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Aug 2019
Ex-dividend date 4N/A
Last split factor 2277:1000
Last split date 318 Aug 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Mar 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-263,920.00%

Management effectiveness

Return on assets (ttm)-18.32%
Return on equity (ttm)-28.78%

Income statement

Revenue (ttm)15k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)0.00%
Gross profit (ttm)15k
EBITDA N/A
Net income avi to common (ttm)-37.38M
Diluted EPS (ttm)-0.5780
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)81.93M
Total cash per share (mrq)1.05
Total debt (mrq)484k
Total debt/equity (mrq)0.36
Current ratio (mrq)18.11
Book value per share (mrq)1.70

Cash flow statement

Operating cash flow (ttm)-35.54M
Levered free cash flow (ttm)-22.91M